LD-2 disclosure · 3rd Quarter - Report
ACER THERAPEUTICS
Income$20Kfee reported
Client
- Description
- therapies for serious rare and life-threatening diseases with critical unmet medical need
- Location
- Massachusetts · United States of America
Registrant
- Description
- Government Affairs Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issuePharmacy
No specific legislative vehicles. Issues are, generally, orphan drug legislation, rare disease legislation, drug pricing policy
LobbyistsDEBORAH LYNN BURRELL
TargetedSENATE · HOUSE OF REPRESENTATIVES